Literature DB >> 11727867

Ovarian reserve testing and the use of prognostic models in patients with subfertility.

A Bukman1, M J Heineman.   

Abstract

The decline in fecundity with female age is a well-known phenomenon for clinicians dealing with subfertility patients. Diminishing ovarian reserve seems to be the reason for declining fecundity. Since age is only a rough estimate of ovarian reserve, many tests have been developed to predict ovarian reserve more precisely. This review focuses on these ovarian reserve tests and their clinical role in predicting response to ovarian stimulation and pregnancy chances. According to our analysis, the clomiphene citrate challenge test has the strongest correlation in predicting ovarian reserve, and is the only test that is validated in the general infertility population. The antral follicle count by ultrasound is promising and may offer clinical use. It is not known whether a combination of tests can provide more accurate information of ovarian reserve. It is not yet clear to which extent the results of ovarian reserve tests can be incorporated into the available prognostic models. There is a need for prospective cohort studies that focus on prognostic factors among which are the results of ovarian reserve tests. Only then can the qualitative and quantitative relevance of ovarian reserve testing in the context of the prognosis for couples with subfertility be established.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727867     DOI: 10.1093/humupd/7.6.581

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  14 in total

1.  Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.

Authors:  Barbara Sonntag; Ludwig Kiesel; Eberhard Nieschlag; Hermann M Behre
Journal:  J Assist Reprod Genet       Date:  2004-07       Impact factor: 3.412

2.  Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF.

Authors:  D J Hendriks; F J Broekmans; L F J M M Bancsi; C W N Looman; F H de Jong; E R te Velde
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

3.  Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.

Authors:  Mehmet Firat Mutlu; Mehmet Erdem; Ahmet Erdem; Sule Yildiz; Ilknur Mutlu; Ozgur Arisoy; Mesut Oktem
Journal:  J Assist Reprod Genet       Date:  2013-03-19       Impact factor: 3.412

Review 4.  Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse.

Authors:  Lingling Salang; Danielle M Teixeira; Ivan Solà; Jen Sothornwit; Wellington P Martins; Magdalena Bofill Rodriguez; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2022-08-24

5.  The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular menstrual cycles.

Authors:  V S Kalaiselvi; Saikumar P; Prabhu K; Prashanth Krishna G
Journal:  J Clin Diagn Res       Date:  2012-11-12

6.  Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.

Authors:  Mehmet Erdem; Ahmet Erdem; Rifat Gursoy; Kutay Biberoglu
Journal:  J Assist Reprod Genet       Date:  2004-02       Impact factor: 3.412

7.  Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin's disease.

Authors:  Foad Azem; Nivin Samara; Tanya Cohen; Dalit Ben-Yosef; Beni Almog; Joseph B Lessing; Odeliya Goor; Ami Amit
Journal:  J Assist Reprod Genet       Date:  2008-11-18       Impact factor: 3.412

8.  Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI.

Authors:  Gültekin Adanaş Aydın; Arzu Yavuz; Hasan Terzi; Tayfun Kutlu
Journal:  Iran J Reprod Med       Date:  2015-04

9.  Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women.

Authors:  Alireza Raeissi; Alireza Torki; Ali Moradi; Seyed Mehdi Mousavipoor; Masoud Doosti Pirani
Journal:  Int J Fertil Steril       Date:  2015-04-21

Review 10.  Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers.

Authors:  Zehra Jamil; Syeda Sadia Fatima; Khalid Ahmed; Rabia Malik
Journal:  Dis Markers       Date:  2016-02-10       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.